The data revealed that cells with SLC7A11 knockdown exhibited heightened susceptibility to ferroptosis, suggesting that targeting SLC7A11 may enhance the effectiveness of ferroptosis agents and represent a viable strategy for sensitizing NSCLC cells to oxidative stress‐based therapies. This evidence concerns the gene SLC7A11 and non-small cell lung carcinoma.